Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC

Rank in Stocks #33935
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Share Price
$0.016
Last synced: 2026-11-18
Market Cap
$83.75K
Change (1 day)
6.67%
Change (1 year)
60.00%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Category

Healthcare
EPS for Vincerx Pharma, Inc. (VINC)
EPS as of March 2025 TTM: $-4.22
According to Vincerx Pharma, Inc.'s latest financial reports, its current EPS (TTM) is $-4.22. At the end of 2024 the company had an EPS of $-5.75, an increase over its 2023 EPS of $-6.84.
EPS history for Vincerx Pharma, Inc. from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-4.22 -26.61%
2024 $-5.75 -15.94%
2023 $-6.84 -37.02%
2022 $-10.86 30.84%
2021 $-8.30 -28.88%
2020 $-11.67 37,065.61%
2019 $-0.03 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 -471.09%
US
$-7.07 67.54%
US
$-5.29 25.36%
AU
$12.73 -401.71%
BE
$21.56 -610.90%
NL

Questions about Vincerx Pharma, Inc.'s earnings per share (EPS)

What is Vincerx Pharma, Inc.'s earnings per share (EPS)?

Vincerx Pharma, Inc.'s earnings per share (EPS) over the last twelve months is $-4.22, as of Mar 2025.

What was Vincerx Pharma, Inc.'s earnings per share (EPS) in 2024?

In 2024, Vincerx Pharma, Inc.'s earnings per share (EPS) was $-5.75, compared with $-6.84 in 2023.

How has Vincerx Pharma, Inc.'s earnings per share (EPS) changed since 2019?

From 2019 to 2024, Vincerx Pharma, Inc.'s earnings per share (EPS) was highest in 2019 ($-0.03) and lowest in 2020 ($-11.67).

How does Vincerx Pharma, Inc.'s earnings per share (EPS) compare with similar companies?

Vincerx Pharma, Inc.'s earnings per share (EPS) ($-4.22) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.